Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment.

Helmers SB, Bruton M, Loell I, Ulfgren AK, Gracie AJ, McInnes IB, Lundberg IE.

Rheumatology (Oxford). 2018 Dec 1;57(12):2149-2157. doi: 10.1093/rheumatology/key222.

PMID:
30102381
2.

The value of preoperative grade of radiographic and histological changes in predicting pain relief after total knee arthroplasty for osteoarthritis.

Lundblad H, Kreicbergs A, Söderlund V, Ulfgren AK, Stiller CO, Jansson KÅ.

Knee Surg Sports Traumatol Arthrosc. 2012 Sep;20(9):1815-21. doi: 10.1007/s00167-011-1821-5. Epub 2011 Dec 20.

PMID:
22183735
3.

Evaluation of arthroscopy and macroscopic scoring.

af Klint E, Catrina AI, Matt P, Neregråd P, Lampa J, Ulfgren AK, Klareskog L, Lindblad S.

Arthritis Res Ther. 2009;11(3):R81. doi: 10.1186/ar2714. Epub 2009 Jun 2.

4.

CD153 in rheumatoid arthritis: detection of a soluble form in serum and synovial fluid, and expression by mast cells in the rheumatic synovium.

Carvalho RF, Ulfgren AK, Engström M, Klint Ea, Nilsson G.

J Rheumatol. 2009 Mar;36(3):501-7. doi: 10.3899/jrheum.080288. Epub 2009 Jan 22.

PMID:
19208589
5.

Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.

Grundtman C, Tham E, Ulfgren AK, Lundberg IE.

Arthritis Rheum. 2008 Oct;58(10):3224-38. doi: 10.1002/art.23884.

6.

Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis.

Muratov V, Ulfgren AK, Engström M, Elvin K, Winqvist O, Löfberg R, Lundahl J.

J Gastroenterol. 2008;43(4):277-82. doi: 10.1007/s00535-007-2156-3. Epub 2008 May 6.

PMID:
18458843
7.

Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells.

Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI.

Ann Rheum Dis. 2008 Oct;67(10):1488-92. doi: 10.1136/ard.2007.075192. Epub 2008 Apr 15.

PMID:
18413445
8.

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.

Sundberg E, Grundtman C, Af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U.

Arthritis Res Ther. 2008;10(2):R33. doi: 10.1186/ar2387. Epub 2008 Mar 17.

9.

Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.

Eklöw C, Makrygiannakis D, Bäckdahl L, Padyukov L, Ulfgren AK, Lorentzen JC, Malmström V.

Ann Rheum Dis. 2008 Dec;67(12):1742-9. doi: 10.1136/ard.2007.076976. Epub 2008 Feb 4.

PMID:
18250113
10.

Urticaria Neonatorum: accumulation of tryptase-expressing mast cells in the skin lesions of newborns with Erythema Toxicum.

Nelson A, Ulfgren AK, Edner J, Ståbi B, Brismar H, Hultenby K, Marchini G.

Pediatr Allergy Immunol. 2007 Dec;18(8):652-8.

PMID:
18078419
11.

Increased expression of HMGB-1 in the skin lesions of erythema toxicum.

Marchini G, Hultenby K, Nelson A, Yektaei-Karin E, Ståbi B, Lonne-Rahm S, Ulfgren AK, Brismar H.

Pediatr Dermatol. 2007 Sep-Oct;24(5):474-82.

PMID:
17958791
12.

Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis.

Fasth AE, Snir O, Johansson AA, Nordmark B, Rahbar A, Af Klint E, Björkström NK, Ulfgren AK, van Vollenhoven RF, Malmström V, Trollmo C.

Arthritis Res Ther. 2007;9(5):R87.

13.

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.

Eloranta ML, Barbasso Helmers S, Ulfgren AK, Rönnblom L, Alm GV, Lundberg IE.

Arthritis Rheum. 2007 Sep;56(9):3112-24.

14.

Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis.

Rooney T, Bresnihan B, Andersson U, Gogarty M, Kraan M, Schumacher HR, Ulfgren AK, Veale DJ, Youssef PP, Tak PP.

Ann Rheum Dis. 2007 Dec;66(12):1656-60. Epub 2007 Jun 29.

15.

High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis.

Magnusson SE, Engström M, Jacob U, Ulfgren AK, Kleinau S.

Arthritis Res Ther. 2007;9(3):R51.

16.

Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.

Hashimoto A, Tarner IH, Bohle RM, Gaumann A, Manetti M, Distler O, Steinmeyer J, Ulfgren AK, Schulz A, Gay S, Müller-Ladner U, Neumann E.

Arthritis Rheum. 2007 Apr;56(4):1094-105.

17.

Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.

Bresnihan B, Gerlag DM, Rooney T, Smeets TJ, Wijbrandts CA, Boyle D, Fitzgerald O, Kirkham BW, McInnes IB, Smith M, Ulfgren AK, Veale DJ, Tak PP.

J Rheumatol. 2007 Mar;34(3):620-2.

PMID:
17343309
18.

Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.

Wittkowski H, Foell D, af Klint E, De Rycke L, De Keyser F, Frosch M, Ulfgren AK, Roth J.

Ann Rheum Dis. 2007 Aug;66(8):1020-5. Epub 2007 Jan 12.

19.

Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients.

Lindberg J, af Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, Lundeberg J.

Arthritis Res Ther. 2006;8(6):R179.

20.

Inflammatory cell and cytokine patterns in patients with chronic polyarthritis and temporomandibular joint involvement.

Kardel R, Ulfgren AK, Reinholt F, Hamada Y, Holmlund A.

Acta Odontol Scand. 2006 Aug;64(4):221-6.

PMID:
16829497
21.

Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.

Makrygiannakis D, af Klint E, Catrina SB, Botusan IR, Klareskog E, Klareskog L, Ulfgren AK, Catrina AI.

Arthritis Rheum. 2006 May;54(5):1463-72.

22.

Citrullination is an inflammation-dependent process.

Makrygiannakis D, af Klint E, Lundberg IE, Löfberg R, Ulfgren AK, Klareskog L, Catrina AI.

Ann Rheum Dis. 2006 Sep;65(9):1219-22. Epub 2006 Mar 15.

23.

Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Löfberg R.

Int J Colorectal Dis. 2006 Sep;21(6):493-504. Epub 2006 Mar 15.

PMID:
16538495
24.

Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology.

Lindberg J, af Klint E, Ulfgren AK, Stark A, Andersson T, Nilsson P, Klareskog L, Lundeberg J.

Arthritis Res Ther. 2006;8(2):R47. Epub 2006 Feb 16.

25.

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.

Ernestam S, af Klint E, Catrina AI, Sundberg E, Engström M, Klareskog L, Ulfgren AK.

Arthritis Res Ther. 2006;8(1):R18.

26.

Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.

Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.

Arthritis Rheum. 2006 Jan;54(1):76-81.

27.

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.

Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, Rönnelid J, Harris HE, Ulfgren AK, Rantapää-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L.

Arthritis Rheum. 2006 Jan;54(1):38-46.

28.

Synovial tissue analysis in clinical trials.

Bresnihan B, Baeten D, Firestein GS, Fitzgerald OM, Gerlag DM, Haringman JJ, McInnes IB, Reece RJ, Smith MD, Ulfgren AK, Veale DJ, Tak PP; OMERACT 7 Special Interest Group.

J Rheumatol. 2005 Dec;32(12):2481-4. Review.

PMID:
16331792
29.

Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.

af Klint E, Grundtman C, Engström M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK.

Arthritis Rheum. 2005 Dec;52(12):3880-9.

30.

Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.

Korotkova M, Westman M, Gheorghe KR, af Klint E, Trollmo C, Ulfgren AK, Klareskog L, Jakobsson PJ.

Arthritis Rheum. 2005 Nov;52(11):3439-47.

31.

Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Smith MD, Baeten D, Ulfgren AK, McInnes IB, Fitzgerald O, Bresnihan B, Tak PP, Veale D; OMERACT synovial special interests group.

Ann Rheum Dis. 2006 Jan;65(1):93-100. Epub 2005 Jun 23. Review.

32.

The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy.

Aronsson A, Ulfgren AK, Ståbi B, Stavreus-Evers A, Gemzell-Danielsson K.

Contraception. 2005 Jul;72(1):33-9.

PMID:
15964290
33.

Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK.

Arthritis Rheum. 2005 Jan;52(1):61-72.

34.

Nitric oxide formation in the oropharyngeal tract: possible influence of cigarette smoking.

Marteus H, Mavropoulos A, Palm JP, Ulfgren AK, Bergström J, Alving K.

Nitric Oxide. 2004 Nov;11(3):247-55.

PMID:
15566971
35.

Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.

Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo C, Ulfgren AK, Swedenborg J, Fei GZ, Frostegård J.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):198-203. Epub 2004 Nov 11.

PMID:
15539620
36.

Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.

Westman M, Korotkova M, af Klint E, Stark A, Audoly LP, Klareskog L, Ulfgren AK, Jakobsson PJ.

Arthritis Rheum. 2004 Jun;50(6):1774-80.

37.
38.

Inflammatory cell and cytokine patterns in patients with painful clicking and osteoarthritis in the temporomandibular joint.

Kardel R, Ulfgren AK, Reinholt FP, Holmlund A.

Int J Oral Maxillofac Surg. 2003 Aug;32(4):390-6.

PMID:
14505622
39.

Low IL-1alpha expression in bladder cancer tissue and survival.

Seddighzadeh M, Larsson P, Ulfgren AC, Onelöv E, Berggren P, Tribukait B, Torstensson A, Norming U, Wijkström H, Linder S, Steineck G.

Eur Urol. 2003 Apr;43(4):362-8.

PMID:
12667716
40.

The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa.

Marchini G, Lindow S, Brismar H, Ståbi B, Berggren V, Ulfgren AK, Lonne-Rahm S, Agerberth B, Gudmundsson GH.

Br J Dermatol. 2002 Dec;147(6):1127-34.

PMID:
12452861
41.

Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.

Hansson T, Ulfgren AK, Lindroos E, DannAEus A, Dahlbom I, Klareskog L.

Scand J Immunol. 2002 Nov;56(5):530-7.

42.

High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.

Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Furie R, Chiorazzi N, Tracey KJ, Andersson U, Harris HE.

Arthritis Rheum. 2002 Oct;46(10):2598-603.

43.

Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium.

Catrina AI, Ulfgren AK, Lindblad S, Grondal L, Klareskog L.

Ann Rheum Dis. 2002 Oct;61(10):934-6.

44.

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.

Catrina AI, Lampa J, Ernestam S, af Klint E, Bratt J, Klareskog L, Ulfgren AK.

Rheumatology (Oxford). 2002 May;41(5):484-9.

PMID:
12011369
45.

Erythema toxicum neonatorum: an immunohistochemical analysis.

Marchini G, Ulfgren AK, Loré K, Ståbi B, Berggren V, Lonne-Rahm S.

Pediatr Dermatol. 2001 May-Jun;18(3):177-87.

PMID:
11437996
46.

Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients.

Olsson N, Ulfgren AK, Nilsson G.

Ann Rheum Dis. 2001 Mar;60(3):187-93.

47.

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.

Ulfgren AK, Andersson U, Engström M, Klareskog L, Maini RN, Taylor PC.

Arthritis Rheum. 2000 Nov;43(11):2391-6.

48.

An immunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis.

Ulfgren AK, Klareskog L, Lindberg M.

Acta Derm Venereol. 2000 May;80(3):167-70.

49.

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Ulfgren AK, Gröndal L, Lindblad S, Khademi M, Johnell O, Klareskog L, Andersson U.

Ann Rheum Dis. 2000 Jun;59(6):439-47.

50.

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK.

Atherosclerosis. 1999 Jul;145(1):33-43.

PMID:
10428293

Supplemental Content

Loading ...
Support Center